Saturday, June 10, 2023
Home Tags Clinical

Tag: clinical

FibroGen Announces Topline Results from LELANTOS-1 Phase 3 Clinical Study of...

0
Study did not meet the primary endpointPamrevlumab was generally safe and well tolerated Topline results from LELANTOS-2 Phase 3 study of pamrevlumab in...

OSE Immunotherapeutics Presents Clinical Abstracts on Tedopi® at the ASCO 2023...

0
Tedopi® is the Company's Most Advanced Product in Clinical Development ATALANTE-1, a Phase 3 clinical trial with positive results comparing Tedopi® to chemotherapy in...

Gencurix Announces Clinical Research Results At ASCO 2023 Demonstrating Outstand… –...

0
SEOUL, South Korea, June 4, 2023 /PRNewswire/ -- Gencurix (KOSDAQ #229000), a leading provider of cancer molecular diagnostics, announced the release of clinical...

77.4% ORR! Abbisko to present the updated clinical phase Ib data...

0
SHANGHAI, May 28, 2023 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter) today announced that the updated results of Phase Ib study...

Enzo Biochem Reports Significant Progress towards Completing the Clinical Lab As…...

0
FARMINGDALE, NY, May 22, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. ENZ, announced today that  the preliminary voting results from...

Nexcella Announces Positive NXC-201 Clinical Results at ASGCT: 100% Overall Resp…...

0
8 AL Amyloidosis patients relapsed/refractory to DARZALEX®-based regimens were treated with CAR-T NXC-201100% (8/8) overall response rate and 63% (5/8) complete response (MRD...

Salubris Biotherapeutics Presents Positive Updates from Phase 1b Clinical Trial …...

0
After a Single Administration of JK07, Patients in All Dose Cohorts Showed Improvement in Ejection Fraction (EF) Through Day 90 JK07 was Generally Safe...

Positive Interim Data of BellaSeno’s Clinical Trial with Resorbable Breast and...

0
Data presented at RACS 91st Annual Scientific Congress 2023Initial findings demonstrate that BellaSeno's resorbable implants are safe, well tolerated and lead to natural...

BLISS BIOPHARMACEUTICAL ENTERS INTO A CLINICAL TRIAL COLLABORATION AGREEMENT WIT… –...

0
HANGZHOU, China, May 7, 2023 /PRNewswire/ -- Bliss Biopharmaceutical (Hangzhou) Co., Ltd, ("BlissBio") a clinical-stage biopharmaceutical company developing differentiated antibody-drug conjugate (ADC) therapeutics,...

Findings From Two Large-Scale, Real-World Data Sets Reinforce Clinical Utility o…...

0
Data from studies encompassing over 100,000 prostate cancer patients presented at American Urology Association (AUA) 2023 Annual Meeting Veracyte, Inc. VCYT announced that new...

Press Realease

Business News

Cricket

Weather News

Lifestyle

World News

UK / USA News

Local News